These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33723614)

  • 21. Psoriasiform eruption induced by anticonvulsants.
    Brenner S; Wolf R; Landau M; Politi Y
    Isr J Med Sci; 1994 Apr; 30(4):283-6. PubMed ID: 8175330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorafenib-associated psoriasiform skin changes.
    Laquer V; Saedi N; Dann F; Kelly K
    Cutis; 2010 Jun; 85(6):301-2. PubMed ID: 20666190
    [No Abstract]   [Full Text] [Related]  

  • 23. Psoriasiform drug eruption due to abatacept.
    Kato K; Satoh T; Nishizawa A; Yokozeki H
    Acta Derm Venereol; 2011 May; 91(3):362-3. PubMed ID: 21336469
    [No Abstract]   [Full Text] [Related]  

  • 24. Psoriasiform skin eruption in a patient receiving certolizumab-pegol for ankylosing spondylitis: Report of a case and review of the literature.
    Babuna Kobaner G; Polat Ekinci A; Yilmaz Z; Copur S
    Dermatol Ther; 2018 Sep; 31(5):e12693. PubMed ID: 30225952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasiform Eruption Secondary to the Use of Adalimumab.
    Esteves PM; Barbalho MG; Cortes JG; Cuzzi T; Sodre CT; Ramos-e-Silva M
    J Drugs Dermatol; 2015 Oct; 14(10):1152-4. PubMed ID: 26461828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is TNF-α Inhibitor-Induced Psoriasiform Dermatitis Always Psoriasiform?
    Wei C; Murphy EC; Zahn J; Friedman AJ
    J Drugs Dermatol; 2020 Oct; 19(10):1009-1010. PubMed ID: 33026774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma.
    Totonchy MB; Ezaldein HH; Ko CJ; Choi JN
    JAMA Dermatol; 2016 May; 152(5):590-2. PubMed ID: 26675815
    [No Abstract]   [Full Text] [Related]  

  • 28. Silicone injection masquerading as HIV-psoriasiform dermatosis.
    Alfalasi AA; Khalfan HG; Abdullgaffar B; Almualla A
    Arch Dermatol; 2012 Oct; 148(10):1212-3. PubMed ID: 23069973
    [No Abstract]   [Full Text] [Related]  

  • 29. Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis.
    Cabaleiro T; Prieto-Pérez R; Navarro R; Solano G; Román M; Ochoa D; Abad-Santos F; Daudén E
    Pharmacogenomics J; 2016 Aug; 16(4):336-40. PubMed ID: 26194362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
    Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
    Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor.
    Mas-Vidal A; Santos-Juanes J; Esteve-Martinez A; Caminal-Montero L; Coto-Segura P
    Australas J Dermatol; 2012 Feb; 53(1):70-2. PubMed ID: 22309337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasiform fixed drug eruption caused by nimesulide.
    Katoulis AC; Bozi E; Kanelleas A; Makris M; Alevizou A; Panagiotides I; Stavrianeas NG
    Clin Exp Dermatol; 2009 Oct; 34(7):e360-1. PubMed ID: 19486051
    [No Abstract]   [Full Text] [Related]  

  • 33. Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma.
    Diamantis ML; Chon SY
    J Drugs Dermatol; 2010 Feb; 9(2):169-71. PubMed ID: 20214183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A very rare side effect of mitomycin-C: psoriasiform drug eruption.
    Cicek D; Cobanoglu B; Inci R; Dertlioglu SB; Kokcam I; Elkiran T
    Int J Dermatol; 2013 Dec; 52(12):1572-4. PubMed ID: 24261729
    [No Abstract]   [Full Text] [Related]  

  • 35. Psoriasiform eruption induced by alpha1-adrenergic blocker, urapidil.
    Takehara Y; Igawa K; Satoh T; Yokozeki H
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):577-8. PubMed ID: 17374017
    [No Abstract]   [Full Text] [Related]  

  • 36. Psoriasiform and pustular eruption induced by etanercept and infliximab.
    Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
    Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
    [No Abstract]   [Full Text] [Related]  

  • 37. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease.
    George LA; Gadani A; Cross RK; Jambaulikar G; Ghazi LJ
    Dig Dis Sci; 2015 Nov; 60(11):3424-30. PubMed ID: 26115749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction.
    O’Brien KF; Maiman RE; DeWitt CA
    J Drugs Dermatol; 2019 Aug; 18(8):828-830. PubMed ID: 31424716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasiform drug eruption induced by anti-tuberculosis medication: potential role of plasma-cytoid dendritic cells.
    Park JJ; Choi YD; Lee JB; Kim SJ; Lee SC; Won YH; Yun SJ
    Acta Derm Venereol; 2010 May; 90(3):305-6. PubMed ID: 20526555
    [No Abstract]   [Full Text] [Related]  

  • 40. Psoriasiform intradermal test reaction to ABPC in a patient with psoriasis and ABPC allergy.
    Saito S; Ikezawa Z
    J Dermatol; 1990 Nov; 17(11):677-83. PubMed ID: 2151279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.